Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity

J Antimicrob Chemother. 2015 Feb;70(2):630-2. doi: 10.1093/jac/dku402. Epub 2014 Oct 9.
No abstract available

Keywords: HIV; antiretroviral strategy; dual therapy; simplification; tenofovir; toxicity.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • Darunavir
  • Drug Administration Schedule
  • Drug Synergism
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • Humans
  • Lamivudine / administration & dosage
  • Lamivudine / adverse effects
  • Lamivudine / therapeutic use*
  • Ritonavir / administration & dosage
  • Ritonavir / therapeutic use*
  • Sulfonamides / administration & dosage
  • Sulfonamides / adverse effects
  • Sulfonamides / therapeutic use*
  • Treatment Outcome

Substances

  • Sulfonamides
  • Lamivudine
  • Ritonavir
  • Darunavir